PB101 (autologous NK/CIK cell product)

· Precision Biotech Taiwan Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PB101 (autologous NK/CIK cell product), covering 2025-12-09 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer [Phase 1]